nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylergometrine—HTR2A—myenteric nerve plexus—colon cancer	0.0509	0.293	CbGeAlD
Methylergometrine—Vasospasm—Capecitabine—colon cancer	0.0449	0.0577	CcSEcCtD
Methylergometrine—HTR2A—vein—colon cancer	0.0328	0.189	CbGeAlD
Methylergometrine—Ergonovine—ABCB1—colon cancer	0.0229	0.475	CrCbGaD
Methylergometrine—Ventricular fibrillation—Capecitabine—colon cancer	0.02	0.0258	CcSEcCtD
Methylergometrine—Thrombophlebitis—Irinotecan—colon cancer	0.0192	0.0247	CcSEcCtD
Methylergometrine—Thrombophlebitis—Fluorouracil—colon cancer	0.0184	0.0237	CcSEcCtD
Methylergometrine—Cerebrovascular accident—Irinotecan—colon cancer	0.017	0.0218	CcSEcCtD
Methylergometrine—Angina pectoris—Irinotecan—colon cancer	0.014	0.018	CcSEcCtD
Methylergometrine—Sweating increased—Irinotecan—colon cancer	0.014	0.018	CcSEcCtD
Methylergometrine—Angina pectoris—Fluorouracil—colon cancer	0.0134	0.0172	CcSEcCtD
Methylergometrine—Ergotamine—ABCB1—colon cancer	0.0129	0.267	CrCbGaD
Methylergometrine—Thrombophlebitis—Capecitabine—colon cancer	0.0129	0.0165	CcSEcCtD
Methylergometrine—Bromocriptine—ABCB1—colon cancer	0.0124	0.258	CrCbGaD
Methylergometrine—Hallucination—Vincristine—colon cancer	0.0118	0.0151	CcSEcCtD
Methylergometrine—Bradycardia—Irinotecan—colon cancer	0.0117	0.0151	CcSEcCtD
Methylergometrine—Cerebrovascular accident—Capecitabine—colon cancer	0.0114	0.0146	CcSEcCtD
Methylergometrine—HTR2A—endothelium—colon cancer	0.0113	0.0649	CbGeAlD
Methylergometrine—Cardiac disorder—Vincristine—colon cancer	0.011	0.0141	CcSEcCtD
Methylergometrine—Cardiac disorder—Irinotecan—colon cancer	0.0107	0.0137	CcSEcCtD
Methylergometrine—HTR2A—blood vessel—colon cancer	0.0104	0.0599	CbGeAlD
Methylergometrine—Muscle spasms—Irinotecan—colon cancer	0.00964	0.0124	CcSEcCtD
Methylergometrine—Thrombophlebitis—Methotrexate—colon cancer	0.00958	0.0123	CcSEcCtD
Methylergometrine—Sweating increased—Capecitabine—colon cancer	0.00938	0.0121	CcSEcCtD
Methylergometrine—Angina pectoris—Capecitabine—colon cancer	0.00938	0.0121	CcSEcCtD
Methylergometrine—HTR2B—smooth muscle tissue—colon cancer	0.00914	0.0526	CbGeAlD
Methylergometrine—Convulsion—Vincristine—colon cancer	0.00892	0.0115	CcSEcCtD
Methylergometrine—Hypertension—Vincristine—colon cancer	0.00888	0.0114	CcSEcCtD
Methylergometrine—Hypertension—Irinotecan—colon cancer	0.00865	0.0111	CcSEcCtD
Methylergometrine—Cerebrovascular accident—Methotrexate—colon cancer	0.00846	0.0109	CcSEcCtD
Methylergometrine—Anaphylactic shock—Vincristine—colon cancer	0.0084	0.0108	CcSEcCtD
Methylergometrine—Convulsion—Fluorouracil—colon cancer	0.00832	0.0107	CcSEcCtD
Methylergometrine—Nervous system disorder—Vincristine—colon cancer	0.00824	0.0106	CcSEcCtD
Methylergometrine—Haematuria—Capecitabine—colon cancer	0.00818	0.0105	CcSEcCtD
Methylergometrine—Anaphylactic shock—Irinotecan—colon cancer	0.00818	0.0105	CcSEcCtD
Methylergometrine—Chest pain—Fluorouracil—colon cancer	0.00817	0.0105	CcSEcCtD
Methylergometrine—Hyperhidrosis—Vincristine—colon cancer	0.00812	0.0104	CcSEcCtD
Methylergometrine—Nervous system disorder—Irinotecan—colon cancer	0.00802	0.0103	CcSEcCtD
Methylergometrine—Hyperhidrosis—Irinotecan—colon cancer	0.00791	0.0102	CcSEcCtD
Methylergometrine—Hypotension—Vincristine—colon cancer	0.00785	0.0101	CcSEcCtD
Methylergometrine—Bradycardia—Capecitabine—colon cancer	0.00784	0.0101	CcSEcCtD
Methylergometrine—Anaphylactic shock—Fluorouracil—colon cancer	0.00783	0.0101	CcSEcCtD
Methylergometrine—Nervous system disorder—Fluorouracil—colon cancer	0.00768	0.00987	CcSEcCtD
Methylergometrine—Tachycardia—Fluorouracil—colon cancer	0.00765	0.00983	CcSEcCtD
Methylergometrine—Hypotension—Irinotecan—colon cancer	0.00764	0.00982	CcSEcCtD
Methylergometrine—Paraesthesia—Vincristine—colon cancer	0.00754	0.00969	CcSEcCtD
Methylergometrine—Paraesthesia—Irinotecan—colon cancer	0.00734	0.00944	CcSEcCtD
Methylergometrine—Hypotension—Fluorouracil—colon cancer	0.00732	0.00941	CcSEcCtD
Methylergometrine—Dyspnoea—Irinotecan—colon cancer	0.00729	0.00937	CcSEcCtD
Methylergometrine—HTR2B—digestive system—colon cancer	0.00721	0.0415	CbGeAlD
Methylergometrine—Tinnitus—Capecitabine—colon cancer	0.00718	0.00923	CcSEcCtD
Methylergometrine—Cardiac disorder—Capecitabine—colon cancer	0.00715	0.00919	CcSEcCtD
Methylergometrine—Paraesthesia—Fluorouracil—colon cancer	0.00703	0.00904	CcSEcCtD
Methylergometrine—Dyspnoea—Fluorouracil—colon cancer	0.00698	0.00898	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Vincristine—colon cancer	0.00687	0.00883	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Irinotecan—colon cancer	0.00669	0.0086	CcSEcCtD
Methylergometrine—Abdominal pain—Vincristine—colon cancer	0.00664	0.00853	CcSEcCtD
Methylergometrine—Abdominal pain—Irinotecan—colon cancer	0.00647	0.00831	CcSEcCtD
Methylergometrine—Muscle spasms—Capecitabine—colon cancer	0.00645	0.00829	CcSEcCtD
Methylergometrine—HTR2B—vagina—colon cancer	0.00637	0.0367	CbGeAlD
Methylergometrine—HTR2A—embryo—colon cancer	0.00621	0.0357	CbGeAlD
Methylergometrine—Haematuria—Methotrexate—colon cancer	0.00609	0.00783	CcSEcCtD
Methylergometrine—Palpitations—Capecitabine—colon cancer	0.00593	0.00762	CcSEcCtD
Methylergometrine—Hypertension—Capecitabine—colon cancer	0.00579	0.00744	CcSEcCtD
Methylergometrine—Diarrhoea—Vincristine—colon cancer	0.00575	0.00739	CcSEcCtD
Methylergometrine—Chest pain—Capecitabine—colon cancer	0.00571	0.00734	CcSEcCtD
Methylergometrine—Diarrhoea—Irinotecan—colon cancer	0.0056	0.00719	CcSEcCtD
Methylergometrine—Dizziness—Vincristine—colon cancer	0.00555	0.00714	CcSEcCtD
Methylergometrine—Dizziness—Irinotecan—colon cancer	0.00541	0.00695	CcSEcCtD
Methylergometrine—Nervous system disorder—Capecitabine—colon cancer	0.00537	0.0069	CcSEcCtD
Methylergometrine—Diarrhoea—Fluorouracil—colon cancer	0.00536	0.00689	CcSEcCtD
Methylergometrine—Tinnitus—Methotrexate—colon cancer	0.00535	0.00687	CcSEcCtD
Methylergometrine—Tachycardia—Capecitabine—colon cancer	0.00534	0.00687	CcSEcCtD
Methylergometrine—Vomiting—Vincristine—colon cancer	0.00534	0.00686	CcSEcCtD
Methylergometrine—Cardiac disorder—Methotrexate—colon cancer	0.00532	0.00684	CcSEcCtD
Methylergometrine—Rash—Vincristine—colon cancer	0.0053	0.00681	CcSEcCtD
Methylergometrine—Hyperhidrosis—Capecitabine—colon cancer	0.00529	0.0068	CcSEcCtD
Methylergometrine—Dermatitis—Vincristine—colon cancer	0.00529	0.0068	CcSEcCtD
Methylergometrine—Headache—Vincristine—colon cancer	0.00526	0.00676	CcSEcCtD
Methylergometrine—Vomiting—Irinotecan—colon cancer	0.0052	0.00668	CcSEcCtD
Methylergometrine—Dizziness—Fluorouracil—colon cancer	0.00518	0.00666	CcSEcCtD
Methylergometrine—Rash—Irinotecan—colon cancer	0.00516	0.00663	CcSEcCtD
Methylergometrine—Dermatitis—Irinotecan—colon cancer	0.00515	0.00662	CcSEcCtD
Methylergometrine—Headache—Irinotecan—colon cancer	0.00512	0.00659	CcSEcCtD
Methylergometrine—Hypotension—Capecitabine—colon cancer	0.00512	0.00657	CcSEcCtD
Methylergometrine—HTR2A—epithelium—colon cancer	0.00506	0.0291	CbGeAlD
Methylergometrine—Nausea—Vincristine—colon cancer	0.00499	0.00641	CcSEcCtD
Methylergometrine—Vomiting—Fluorouracil—colon cancer	0.00498	0.0064	CcSEcCtD
Methylergometrine—Rash—Fluorouracil—colon cancer	0.00494	0.00635	CcSEcCtD
Methylergometrine—Dermatitis—Fluorouracil—colon cancer	0.00493	0.00634	CcSEcCtD
Methylergometrine—Paraesthesia—Capecitabine—colon cancer	0.00492	0.00632	CcSEcCtD
Methylergometrine—Headache—Fluorouracil—colon cancer	0.00491	0.00631	CcSEcCtD
Methylergometrine—Dyspnoea—Capecitabine—colon cancer	0.00488	0.00627	CcSEcCtD
Methylergometrine—HTR2A—smooth muscle tissue—colon cancer	0.00488	0.0281	CbGeAlD
Methylergometrine—Nausea—Irinotecan—colon cancer	0.00486	0.00624	CcSEcCtD
Methylergometrine—HTR2A—renal system—colon cancer	0.0047	0.027	CbGeAlD
Methylergometrine—Nausea—Fluorouracil—colon cancer	0.00465	0.00598	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Capecitabine—colon cancer	0.00448	0.00575	CcSEcCtD
Methylergometrine—CYP3A4—renal system—colon cancer	0.00435	0.025	CbGeAlD
Methylergometrine—Abdominal pain—Capecitabine—colon cancer	0.00433	0.00556	CcSEcCtD
Methylergometrine—Convulsion—Methotrexate—colon cancer	0.00433	0.00556	CcSEcCtD
Methylergometrine—Chest pain—Methotrexate—colon cancer	0.00425	0.00546	CcSEcCtD
Methylergometrine—HTR2B—lymph node—colon cancer	0.00412	0.0237	CbGeAlD
Methylergometrine—Anaphylactic shock—Methotrexate—colon cancer	0.00408	0.00524	CcSEcCtD
Methylergometrine—Nervous system disorder—Methotrexate—colon cancer	0.004	0.00514	CcSEcCtD
Methylergometrine—Hyperhidrosis—Methotrexate—colon cancer	0.00394	0.00506	CcSEcCtD
Methylergometrine—HTR2A—digestive system—colon cancer	0.00385	0.0222	CbGeAlD
Methylergometrine—Hypotension—Methotrexate—colon cancer	0.00381	0.00489	CcSEcCtD
Methylergometrine—Diarrhoea—Capecitabine—colon cancer	0.00375	0.00481	CcSEcCtD
Methylergometrine—Paraesthesia—Methotrexate—colon cancer	0.00366	0.0047	CcSEcCtD
Methylergometrine—Dyspnoea—Methotrexate—colon cancer	0.00363	0.00467	CcSEcCtD
Methylergometrine—Dizziness—Capecitabine—colon cancer	0.00362	0.00465	CcSEcCtD
Methylergometrine—CYP3A4—digestive system—colon cancer	0.00357	0.0205	CbGeAlD
Methylergometrine—Vomiting—Capecitabine—colon cancer	0.00348	0.00447	CcSEcCtD
Methylergometrine—Rash—Capecitabine—colon cancer	0.00345	0.00444	CcSEcCtD
Methylergometrine—Dermatitis—Capecitabine—colon cancer	0.00345	0.00443	CcSEcCtD
Methylergometrine—Headache—Capecitabine—colon cancer	0.00343	0.00441	CcSEcCtD
Methylergometrine—HTR2A—vagina—colon cancer	0.0034	0.0196	CbGeAlD
Methylergometrine—Gastrointestinal pain—Methotrexate—colon cancer	0.00333	0.00428	CcSEcCtD
Methylergometrine—Nausea—Capecitabine—colon cancer	0.00325	0.00418	CcSEcCtD
Methylergometrine—Abdominal pain—Methotrexate—colon cancer	0.00322	0.00414	CcSEcCtD
Methylergometrine—HTR2A—liver—colon cancer	0.00287	0.0165	CbGeAlD
Methylergometrine—Diarrhoea—Methotrexate—colon cancer	0.00279	0.00358	CcSEcCtD
Methylergometrine—Dizziness—Methotrexate—colon cancer	0.00269	0.00346	CcSEcCtD
Methylergometrine—CYP3A4—liver—colon cancer	0.00266	0.0153	CbGeAlD
Methylergometrine—Vomiting—Methotrexate—colon cancer	0.00259	0.00333	CcSEcCtD
Methylergometrine—Rash—Methotrexate—colon cancer	0.00257	0.0033	CcSEcCtD
Methylergometrine—Dermatitis—Methotrexate—colon cancer	0.00257	0.0033	CcSEcCtD
Methylergometrine—Headache—Methotrexate—colon cancer	0.00255	0.00328	CcSEcCtD
Methylergometrine—Nausea—Methotrexate—colon cancer	0.00242	0.00311	CcSEcCtD
